Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Connects CD19 on B-cells to CD3 on T-cells, enabling T-cell–mediated cytotoxicity. A leading tool for leukemia and lymphoma research models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

This combination does not exist.

Add to cart Buy now

More Information

This content will be shared across all product pages.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Customer Reviews